ProfileGDS4132 / 227604_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 29% 33% 32% 32% 29% 31% 35% 26% 32% 38% 45% 39% 37% 41% 44% 34% 36% 34% 36% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10169.62429
GSM201543Muscle PCOS pioglitazone 12173.622233
GSM201544Muscle PCOS pioglitazone 16181.425532
GSM201545Muscle PCOS pioglitazone 20186.77932
GSM201829Muscle PCOS pioglitazone 23175.699329
GSM201830Muscle PCOS pioglitazon 25179.996531
GSM201831Muscle PCOS pioglitazone 27186.575535
GSM201832Muscle PCOS pioglitazone 3162.403826
GSM201833Muscle PCOS pioglitazone 4176.250632
GSM201834Muscle PCOS pioglitazone 8196.643638
GSM201835Muscle PCOS after pioglitazone 102104.94245
GSM201836Muscle PCOS after pioglitazone 12288.830839
GSM201837Muscle PCOS after pioglitazone 16279.202537
GSM201838Muscle PCOS after pioglitazone 20296.096841
GSM201839Muscle PCOS after pioglitazone 232108.57844
GSM201840Muscle PCOS after pioglitazone 25282.884434
GSM201841Muscle PCOS after pioglitazone 27278.024736
GSM201842Muscle PCOS after pioglitazone 3269.515134
GSM201843Muscle PCOS after pioglitazone 4287.543536
GSM201844Muscle PCOS after pioglitazone 8291.730938